According to a new report, published by KBV research, The Global Electronic Skin Patch Market size is expected to reach $30 billion by 2031, rising at a market growth of 11.7% CAGR during the forecast period.
The Healthcare segment is leading the Global Electronic Skin Patch Market by End User in 2023; thereby, achieving a market value of $18.2 billion by 2031. Electronic skin patches are designed for medical and clinical applications, making them highly relevant and beneficial for healthcare providers and institutions. These patches continuously monitor vital signs, physiological parameters, and biometric data, facilitating early detection of health abnormalities, timely interventions, and personalized patient care.
The Therapeutic segment is registering a CAGR of 12.6% during (2024 - 2031). The noninvasive drug delivery platform provided by electronic skin patches makes targeted delivery of medicinal drugs through the skin, avoiding the gastrointestinal tract and first-pass metabolism. This route of administration is particularly advantageous for drugs that are poorly absorbed orally, have low bioavailability, or cause gastrointestinal side effects, making electronic skin patches an attractive option for delivering a wide range of therapeutic compounds.
The Connected segment dominated the Global Electronic Skin Patch Market by Wireless Connectivity in 2023; thereby, achieving a market value of $20.7 billion by 2031. Skin patches enable real-time monitoring of physiological parameters, health metrics, and biometric data, providing continuous insights into patients’ health status and allowing healthcare providers to track changes over time. Real-time data monitoring facilitates early detection of health abnormalities, timely interventions, and proactive management of chronic conditions, enhancing patient outcomes and reducing healthcare costs.
The Cardiovascular Monitoring segment is anticipating a CAGR of 10.4% during (2024 - 2031). Electronic skin patches equipped with ECG sensors enable the detection and monitoring of arrhythmias, such as atrial fibrillation (AFib), ventricular tachycardia (VT), and bradycardia. These patches can detect subtle changes in heart rhythm, capture irregularities in ECG signals, and provide alerts to users and healthcare providers when arrhythmias are detected, enabling timely interventions and managing cardiovascular conditions.
Full Report: https://www.kbvresearch.com/electronic-skin-patch-market/
The North America region dominated the Global Electronic Skin Patch Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $11.5 billion by 2031. The Europe region is experiencing a CAGR of 11.3% during (2024 - 2031). Additionally, The Asia Pacific region would exhibit a CAGR of 12.5% during (2024 - 2031).
By End User
By Type
By Wireless Connectivity
By Application
Unique Offerings 
